Delivery Order SPE2DB20D3111-SPE2DB25FA6FZ

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMHVD, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,318.69, is for the delivery of 4,567,235,577 units of Losartan Potassium 50 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,083 firm-fixed-price delivery order is for the supply of 4,564,015,207 units of Losartan Potassium 50 mg tablets. The contract has an ultimate completion date of March 20, 2024 and does not have any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,566.06 firm-fixed-price delivery order is for the supply of 4,561,834,817 units of Losartan Potassium 50 mg tablets. The contract has an ultimate completion date of August 17, 2023 and was awarded on August 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,072.77 firm fixed-price delivery order is for the supply of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of April 21, 2023 and was awarded on April 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,981.18, is for the delivery of 4,566,250 units of Losartan Potassium 100 mg tablets, a medication used to treat high blood pressure and heart failure. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 29, 2024. This award is not associated with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,263.54, is a Delivery Order for the supply of 50 mg Losartan Potassium tablets. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $1,757.52, is a Delivery Order for the supply of 4,566,087,289 units of Losartan Potassium 50 mg tablets. The award is not designated as a set-aside contract and has a completion date of October 15, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,450.90, is a delivery order for the supply of Losartan Potassium 50 mg Tablets in 1,000-count packages. The contract has an ultimate completion date of November 29, 2024, and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $12,274.42, is for the delivery of 4,566,914,687 units of Losartan Potassium 50 mg tablets. This is a Firm Fixed Price Delivery Order contract with a performance period that runs through January 14, 2025. The contract was awarded on January 13, 2025 and was not set aside for any...
This federal contract award is for the delivery of 4,561,389,204 units of Losartan Potassium 50 mg tablets in quantities of 1,000. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a firm fixed price of $3,013.64 and an ultimate completion date of July 3, 2023. The contract is a delivery order and does not have a set-aside designation, indicating open...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA6FZ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,415.25 for the delivery of 4,566,949,578 units of Losartan Potassium 50 mg tablets. The award has an ultimate completion date of January 16, 2025 and a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating it was open competition.

Generated 5/21/25, 9:50 AM